AHCDO has endorsed the the "COVID-19 vaccination guidance for people with bleeding disorders" published jointly, in December 2020, by the WFH, EAHAD, EHC and the NHF
The Guidelines for the Management of Haemophilia in Australia are now
available, and can be viewed and downloaded from the National Blood
Authority (NBA) website.
The Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy has been published in the Medical Journal of Australia
Federal Health Minister Greg Hunt has announced that Hemlibra®, also known as emicizumab, will be made available to eligible patients free of charge through the National Blood Authority
The Australian Haemophilia Centre Directors' Organisation (AHCDO) has developed the Gene Therapy Roadmap to provide a Clinical Implementation Plan that sets out AHCDO’s position on the preferred approach to implementation of gene therapy for haemophilia in Australia, with a focus on patient needs that is informed by clinical experience.